Tag: SVS VAM 2021

Vascular News’ top 10 most popular stories of August 2021

Research presented at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM 2021; 18–21 August, San Diego, USA and online)—including new VOYAGER PAD...

Medical therapy linked with low early mortality in type B aortic...

Medical management of type B aortic intramural haematomas is associated with low early mortality but a 19% risk of aortic-related intervention—primarily for proximal descending...

Five-year results of the Gore Excluder IBE pivotal study confirm safety,...

W L Gore & Associates (Gore) has announced that five-year results from the US prospective, multicentre study (n=63) evaluating endovascular repair of iliac aneurysms...

Five-year STABLE II results show Zenith system makes the cut for...

Joseph V Lombardi (Cooper University Hospital, Camden, USA) reported long-term outcomes favouring the continued safety and effectiveness of a composite device (proximal covered stent...

First ever analysis of TCAR in standard surgical risk patients demonstrates...

Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularisation...

VOYAGER PAD: Rivaroxaban plus aspirin should be considered after lower extremity...

“A strategy of adding rivaroxaban 2.5mg twice daily to aspirin should be considered after lower extremity bypass regardless of conduit type,” concluded Nicholas Govsyeyev...